Podcast: Learnings with Gene from 30 years in the CDMO space
June 18, 2020
Join our President and CEO, Eugene Ciolfi in this latest episode of the Molecule to Market podcast, where he delves into his take on the outsourcing space of the global drug development sector. Gene has spent over 30 years in the CDMO space working for several renowned companies along the way.
Hosted by, Raman Sehgal, this podcast discusses the pharmaceutical and biotechnology supply chain with Gene, speaking on the transformation of the CDMO landscape over the last 30 years. They address the many changes that have occurred but also the things that have stayed consistent.
They also discuss the benefit of truly ‘value-add’ CDMOs such as MedPharm to small and large drug developers in helping achieve pipeline success and raising the CDMO bar. Lastly, Gene discusses the importance of being okay with making mistakes and addresses trust and integrity as two key pillars in the heavily regulated pharmaceutical and biotech drug development space.
You can delve in with Gene and Raman here:
MedPharm is the world’s leading contract provider of topical and transdermal formulation development and manufacturing services. Our experts specialize in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through cost-effective and industry-leading performance testing models. Well-established as the global leader in dermal and transdermal product development, MedPharm also offers innovative solutions for airway, ophthalmic, otic, ungual, and other topical preparations. With locations in both the US and the UK, MedPharm is the CDMO of choice for developers around the globe.